We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$244B
AUM Growth
-$56.4B
Cap. Flow
-$9.23B
Cap. Flow %
-3.79%
Top 10 Hldgs %
13.08%
Holding
11,816
New
1,264
Increased
3,667
Reduced
5,054
Closed
1,052

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$641M
2
MSFT icon
Microsoft
MSFT
+$477M
3
ACN icon
Accenture
ACN
+$354M
4
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$332M
5
CVX icon
Chevron
CVX
+$304M

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Healthcare 7.02%
3 Financials 6.95%
4 Consumer Discretionary 5.19%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFRD icon
5601
Weatherford International
WFRD
$6.22B
$79K ﹤0.01%
3,720
-2,265
-38% -$72.1K
AMRS
5602
DELISTED
Amyris Inc.
AMRS
$79K ﹤0.01%
42,499
-35,102
-45% -$103K
GROV icon
5603
Grove Collaborative
GROV
$46.1M
$78K ﹤0.01%
3,383
-1,396
-29% -$64K
HYGV icon
5604
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.1B
$78K ﹤0.01%
+1,929
New +$83.6K
RETA
5605
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$78K ﹤0.01%
2,558
+759
+42% +$22.6K
MACC.U
5606
DELISTED
Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant
MACC.U
$78K ﹤0.01%
7,937
MUDS
5607
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$78K ﹤0.01%
7,689
+5,378
+233% +$54.1K
API
5608
Agora
API
$377M
$77K ﹤0.01%
11,713
+6,982
+148% +$49.4K
FOVL
5609
DELISTED
iShares Focused Value Factor ETF
FOVL
$77K ﹤0.01%
1,576
+1,411
+855% +$76.3K
FRPH icon
5610
FRP Holdings
FRPH
$421M
$77K ﹤0.01%
2,562
+1,332
+108% +$38.8K
HROW icon
5611
Harrow
HROW
$1.51B
$77K ﹤0.01%
10,603
-3,599
-25% -$24.3K
NHS
5612
Neuberger High Yield Strategies Fund Inc
NHS
$255M
$77K ﹤0.01%
9,116
-2,559
-22% -$24.2K
NTCT icon
5613
NETSCOUT
NTCT
$2.79B
$77K ﹤0.01%
2,281
-30,450
-93% -$1.02M
NVGS icon
5614
Navigator Holdings
NVGS
$1.28B
$77K ﹤0.01%
6,807
+707
+12% +$9.14K
PNT
5615
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$77K ﹤0.01%
+11,334
New +$86.7K
FLZA
5616
DELISTED
Franklin FTSE South Africa
FLZA
$77K ﹤0.01%
3,394
+3,244
+2,163% +$82.6K
DTP
5617
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$77K ﹤0.01%
+1,505
New +$78.6K
ARKX icon
5618
ARK Space & Defense Innovation ETF
ARKX
$850M
$76K ﹤0.01%
5,720
+1,876
+49% +$28.4K
BALY icon
5619
Bally's
BALY
$658M
$76K ﹤0.01%
3,835
+1,461
+62% +$37.8K
HEEM icon
5620
iShares Currency Hedged MSCI Emerging Markets
HEEM
$288M
$76K ﹤0.01%
2,938
-339
-10% -$8.87K
IBTL icon
5621
iShares iBonds Dec 2031 Term Treasury ETF
IBTL
$655M
$76K ﹤0.01%
3,463
+2,739
+378% +$60K
SILC icon
5622
Silicom
SILC
$242M
$76K ﹤0.01%
2,257
+2,160
+2,227% +$76.9K
WEAT icon
5623
Teucrium Wheat Fund
WEAT
$292M
$76K ﹤0.01%
1,697
-742
-30% -$40K
XENE icon
5624
Xenon Pharmaceuticals
XENE
$6.12B
$76K ﹤0.01%
2,472
+1,249
+102% +$37.8K
AB icon
5625
PUT
AllianceBernstein
AB
$3.47B
$75K ﹤0.01%
1,800
-200
-10% -$8.4K

Similar funds

UBS Group's Q2 2022 Portfolio in Review

As of Q2 2022, UBS Group held 11,816 positions worth $244B, down 19% from $300B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $9.23B in Q2 2022, closing 1,052 positions and reducing 5,054 holdings. Its most notable exit was Cerner Corp, an estimated $177M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS Group opened a new position in iShares 0-3 Month Treasury Bond ETF worth $13.8M.

  • UBS Group's largest Q2 2022 buy was iShares 0-3 Month Treasury Bond ETF: 137,765 shares worth $13.8M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $453M increase.
  • UBS Group's biggest Q2 2022 reduction was Apple, cutting an estimated $641M.
  • UBS Group fully exited Cerner Corp in Q2 2022, selling an estimated $177M.
  • UBS Group's ten largest holdings make up 13% of its $244B portfolio in Q2 2022.
  • UBS Group opened 1,264 new positions and closed 1,052 in Q2 2022.
  • UBS Group's portfolio value fell 19% quarter-over-quarter to $244B.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.